TREATMENT AND POST-TREATMENT EFFECTS OF CHEWABLE FLUORIDE TABLETS ON DENTAL-CARIES AFTER 9 AND 1/2 YEARS - FINAL REPORT

被引:0
|
作者
DRISCOLL, WS [1 ]
HEIFETZ, SB [1 ]
BRUNELLE, JA [1 ]
机构
[1] NIDR,NATL CARIES PROGRAM,BETHESDA,MD 20014
关键词
D O I
暂无
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
引用
收藏
页码:406 / 406
页数:1
相关论文
共 41 条
  • [31] EFFECTIVENESS OF PEGINTERFERON ALFA-2A THERAPY IN HBEAG-POSITIVE AND HBEAG-NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B: FINAL RESULTS 3 YEARS POST-TREATMENT OF THE PROSPECTIVE, GLOBAL, OBSERVATIONAL S-COLLATE STUDY
    Marcellin, P.
    Xie, Q.
    Paik, S. W.
    Flisiak, R.
    Piratvisuth, T.
    Petersen, J.
    Asselah, T.
    Cornberg, M.
    Ouzan, D.
    Foster, G. R.
    Papatheodoridis, G. V.
    Messinger, D.
    Regep, L.
    Bakalos, G.
    Alshuth, U.
    Wedemeyer, H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S598 - S599
  • [32] Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: A report from the Gaucher Registry
    Weinreb, NJ
    Charrow, J
    Andersson, HC
    Kaplan, P
    Kolodny, EH
    Mistry, P
    Pastores, G
    Rosenbloom, BE
    Scott, CR
    Wappner, RS
    Zimran, A
    AMERICAN JOURNAL OF MEDICINE, 2002, 113 (02): : 112 - 119
  • [33] Re-initiation of risedronate 5 mg daily therapy in patients on long-term treatment after 1 year of discontinuation: effects at 9 and 10 years
    Eastell, Richard
    Hannon, Rosemary
    Wenderoth, Dietrich
    BONE, 2010, 46 : S23 - S24
  • [34] Long-term treatment response based on severity of Gaudier disease type 1 at baseline after 8 years of treatment with oral eliglustat: Final efficacy and safety results from a phase 2 clinical trial in treatment-naive adult patients
    Lau, Heather A.
    Lukina, Elena
    Watman, Nora
    Dragosky, Marta
    Avila Arreguin, Elsa
    Rosenbaum, Hanna
    Wu, Yaoshi
    Gaemers, Sebastiaan J. M.
    Peterschmitt, M. Judith
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S83 - S83
  • [35] Acute myeloid leukemia with t(16;21)(q24;q22), CBFA2T3::RUNX1, in post-treatment setting, a case report
    Yang, T.
    Khan, A., I
    Hanan, A.
    Kataria, N.
    Khan, A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S72 - S72
  • [36] Acute myeloid leukemia with t(16;21)(q24;q22), CBFA2T3::RUNX1, in post-treatment setting, a case report
    Yang, T.
    Khan, A. I.
    Hanan, A.
    Kataria, N.
    Khan, A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S72 - S72
  • [37] The Combined Effects of Clinical Factors and CYP2C9 and VKORC1 Gene Polymorphisms on Initiating Warfarin Treatment in Patients after Cardiac Valve Surgery
    Tatarunas, Vacis
    Lesauskaite, Vaiva
    Veikutiene, Audrone
    Grybauskas, Pranas
    Jakuska, Povilas
    Benetis, Rimantas
    JOURNAL OF HEART VALVE DISEASE, 2012, 21 (05): : 628 - 635
  • [38] Long-term follow-up of HBsAg clearance in patients with HBeAg-negative CHB treated with Peginterferon alfa-2a: Increase in HBsAg, clearance rate from 3% 6 months post-treatment to 8% after 3 years
    Marcellin, Patrick
    Brunetto, Maurizia
    Bonino, Ferruccio
    Lau, George K.
    Farci, Patrizia
    Yurdaydin, Cihan
    Piratvisuth, Teerha
    Luo, K.
    Wang, Y.
    Hadziyannis, Stephanos J.
    Wolf, Eva
    Popescu, Matei
    HEPATOLOGY, 2007, 46 (04) : 673A - 674A
  • [39] BENEFICIAL EFFECTS OF FLASH GLUCOSE MONITORING ON HBA1C AND TREATMENT SATISFACTION PERSISTS AFTER 2 YEARS OF USAGE - A REAL LIFE CLINICAL FOLLOW-UP STUDY
    Londahl, M.
    Filipsson, K.
    Lindholm, E.
    Fagher, K.
    Katzman, P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A42 - A42
  • [40] Early Versus Delayed Endocrine Treatment of T2-T3 pN1-3 M0 Prostate Cancer Without Local Treatment of the Primary Tumour: Final Results of European Organisation for the Research and Treatment of Cancer Protocol 30846 After 13 Years of Follow-up (A Randomised Controlled Trial)
    Schroder, Fritz H.
    Kurth, Karl-Heinz
    Fossa, Sophie D.
    Hoekstra, Wytse
    Karthaus, Peter P.
    De Prijck, Linda
    Collette, Laurence
    EUROPEAN UROLOGY, 2009, 55 (01) : 14 - 22